<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35370620</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-4365</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in aging neuroscience</Title><ISOAbbreviation>Front Aging Neurosci</ISOAbbreviation></Journal><ArticleTitle>COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study.</ArticleTitle><Pagination><StartPage>804937</StartPage><MedlinePgn>804937</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">804937</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnagi.2022.804937</ELocationID><Abstract><AbstractText>COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been often characterized as a respiratory disease. However, it is increasingly being understood as an infection that impacts multiple systems, and many patients report neurological symptoms. Indeed, there is accumulating evidence for neural damage in some individuals, with recent studies suggesting loss of gray matter in multiple regions, particularly in the left hemisphere. There are several mechanisms by which the COVID-19 infection may lead to neurological symptoms and structural and functional changes in the brain, and cognitive problems are one of the most commonly reported symptoms in those experiencing Long COVID - the chronic illness following the COVID-19 infection that affects between 10 and 25% of patients. However, there is yet little research testing cognition in Long COVID. The COVID and Cognition Study is a cross-sectional/longitudinal study aiming to understand cognitive problems in Long COVID. The first paper from the study explored the characteristics of our sample of 181 individuals who had experienced the COVID-19 infection, and 185 who had not, and the factors that predicted ongoing symptoms and self-reported cognitive deficits. In this second paper from the study, we assess this sample on tests of memory, language, and executive function. We hypothesize that performance on "objective" cognitive tests will reflect self-reported cognitive symptoms. We further hypothesize that some symptom profiles may be more predictive of cognitive performance than others, perhaps giving some information about the mechanism. We found a consistent pattern of memory deficits in those that had experienced the COVID-19 infection, with deficits increasing with the severity of self-reported ongoing symptoms. Fatigue/Mixed symptoms during the initial illness and ongoing neurological symptoms were predictive of cognitive performance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Guo, Benito Ballesteros, Yeung, Liu, Saha, Curtis, Kaser, Haggard and Cheke.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Panyuan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benito Ballesteros</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Sabine P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ruby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Arka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Lyn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Psychology, College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaser</LastName><ForeName>Muzaffer</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haggard</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheke</LastName><ForeName>Lucy G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Aging Neurosci</MedlineTA><NlmUniqueID>101525824</NlmUniqueID><ISSNLinking>1663-4365</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">executive functions</Keyword><Keyword MajorTopicYN="N">language</Keyword><Keyword MajorTopicYN="N">memory</Keyword><Keyword MajorTopicYN="N">neurological</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35370620</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alberti P., Beretta S., Piatti M., Karantzoulis A., Piatti M. L., Santoro P., et al. (2020). Guillain-Barr&#xe9; syndrome related to COVID-19 infection. Neurol.Neuroimmunol. Neuroinflamm. 7 e741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217652</ArticleId><ArticleId IdType="pubmed">32350026</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F., Houdayer E., Parma A., Spina A., Del Forno A., Scatolini A., et al. (2021). COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. Plos one 16:e0246590. 10.1371/journal.pone.0246590</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J. C., Sotoca J., Deus J., Krupinski J. (2020). Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav. Immunityhealth 9:100163. 10.1016/j.bbih.2020.100163</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwyl-Irvine A. L., Massonni&#xe9; J., Flitton A., Kirkham N., Evershed J. K. (2020). Gorilla in our midst: an online behavioral experiment builder. Behav. Res. Methods 52 388&#x2013;407. 10.3758/s13428-019-01237-x</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13428-019-01237-x</ArticleId><ArticleId IdType="pmc">PMC7005094</ArticleId><ArticleId IdType="pubmed">31016684</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R., Adams M. E., Benjamin L., Cohen H., Farmer S. F., Goh Y. Y., et al. (2020). Characteristics of ischaemic stroke associated with COVID-19. J. Neurol. Neurosurg. Psychiatr. 91 889&#x2013;891. 10.1136/jnnp-2020-323586</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323586</ArticleId><ArticleId IdType="pmc">PMC7231545</ArticleId><ArticleId IdType="pubmed">32354768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O. B., Nissen J., Cantwell L., Schwinn M., et al. (2021). Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Scientific Rep. 11 1&#x2013;11. 10.1038/s41598-021-92045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougakov D., Podell K., Goldberg E. (2021). Multiple neuroinvasive pathways in COVID-19. Mol. Neurobiol. 58 564&#x2013;575. 10.1007/s12035-020-02152-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02152-5</ArticleId><ArticleId IdType="pmc">PMC7523266</ArticleId><ArticleId IdType="pubmed">32990925</ArticleId></ArticleIdList></Reference><Reference><Citation>Brydon L., Harrison N. A., Walker C., Steptoe A., Critchley H. D. (2008). Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatr. 63 1022&#x2013;1029. 10.1016/j.biopsych.2007.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2007.12.007</ArticleId><ArticleId IdType="pmc">PMC2885493</ArticleId><ArticleId IdType="pubmed">18242584</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. (2021). How and why patients made Long Covid. Soc. Sci. Med. 268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W. W., Zhang X., Huang W. J. (2016). Role of neuroinflammation in neurodegenerative diseases. Mol. Med. Rep. 13 3391&#x2013;3396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805095</ArticleId><ArticleId IdType="pubmed">26935478</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E., Barrett K. M. S., Riffle S., Bolze A., Neveux I., Dabe S., et al. (2020). Long-term COVID-19 symptoms in a large unselected population. [preprint]. 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R., O&#x2019;Connor J. C., Freund G. G., Johnson R. W., Kelley K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 46&#x2013;56. 10.1038/nrn2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Das G., Mukherjee N., Ghosh S. (2020). Neurological insights of COVID-19 pandemic. ACS Chem. Neurosci. 11 1206&#x2013;1209.</Citation><ArticleIdList><ArticleId IdType="pubmed">32320211</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re&#x2019;em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClin. Med. 38:3820561. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin G. A., Snyder H., Carrillo M., Hosseini A. A., Brugha T. S., Seshadri S., et al. (2021). The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning. Alzheimer&#x2019;s Dement. 17 1056&#x2013;1065. 10.1002/alz.12255</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Xu J., Zhou J., Long Q. (2020). Chest CT findings of COVID-19 pneumonia by duration of symptoms. Euro. J. Radiol. 127:109009. 10.1016/j.ejrad.2020.109009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109009</ArticleId><ArticleId IdType="pmc">PMC7165099</ArticleId><ArticleId IdType="pubmed">32325282</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., Lange F., et al. (2021). Brain imaging before and after COVID-19 in UK Biobank. medRxiv [preprint]. 10.1101/2021.06.11.21258690</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId><ArticleId IdType="pmc">PMC8240690</ArticleId><ArticleId IdType="pubmed">34189535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlenbach W. J., Hough C. L., Crane P. K., Haneuse S. J., Carson S. S., Curtis J. R., et al. (2010). Association between acute care and critical illness hospitalization and cognitive function in older adults. Jama 303 763&#x2013;770. 10.1001/jama.2010.167</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.167</ArticleId><ArticleId IdType="pmc">PMC2943865</ArticleId><ArticleId IdType="pubmed">20179286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekdahl C. T., Claasen J.-H., Bonde S., Kokaia Z., Lindvall O. (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. 100 13632&#x2013;13637. 10.1073/pnas.2234031100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2234031100</ArticleId><ArticleId IdType="pmc">PMC263865</ArticleId><ArticleId IdType="pubmed">14581618</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanopoulou A. S., Ferastraoaru V., Correa D. J., Cherian K., Duberstein S., Gursky J., et al. (2020). EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: a small case series preliminary report. Epilepsia Open 5 314&#x2013;324. 10.1002/epi4.12399</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/epi4.12399</ArticleId><ArticleId IdType="pmc">PMC7289172</ArticleId><ArticleId IdType="pubmed">32537529</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimeno D., Kivim&#xe4;ki M., Brunner E. J., Elovainio M., De Vogli R., Steptoe A., et al. (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39 413&#x2013;423. 10.1017/S0033291708003723</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291708003723</ArticleId><ArticleId IdType="pmc">PMC2788760</ArticleId><ArticleId IdType="pubmed">18533059</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard T. D., Jackson J. C., Pandharipande P. P., Pun B. T., Thompson J. L., Shintani A. K., et al. (2010). Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Critic. care Med. 38:1513. 10.1097/CCM.0b013e3181e47be1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181e47be1</ArticleId><ArticleId IdType="pmc">PMC3638813</ArticleId><ArticleId IdType="pubmed">20473145</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E. L., Clark J. R., Orban Z. S., Lim P. H., Szymanski A. L., Taylor C., et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 8 1073&#x2013;1085. 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau-Olivares M., Arboix A. (2009). Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Exp. Rev. Neurother. 9 1201&#x2013;1217. 10.1586/ern.09.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/ern.09.73</ArticleId><ArticleId IdType="pubmed">19673608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Ballesteros A. B., Yeung S. P., Liu R., Saha A., Curtis L., et al. (2022). COVCOG 1: factors predicting cognitive symptoms in Long COVID. A first publication from the COVID and Cognition Study.&#x201d;. medRxiv [preprint]. 10.1101/2021.10.26.21265525</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.26.21265525</ArticleId><ArticleId IdType="pmc">PMC8968323</ArticleId><ArticleId IdType="pubmed">35370617</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak&#x2013;an update on the status. Military Med. Res. 7 1&#x2013;10. 10.1186/s40779-020-00240-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-00240-0</ArticleId><ArticleId IdType="pmc">PMC7068984</ArticleId><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S. R., Jolly A. E., Grant J. E., Patrick F., et al. (2021). Cognitive deficits in people who have recovered from COVID-19. EClin. Med. 39:101044. 10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison N. A., Brydon L., Walker C., Gray M. A., Steptoe A., Critchley H. D. (2009). Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatr. 66 407&#x2013;414. 10.1016/j.biopsych.2009.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2009.03.015</ArticleId><ArticleId IdType="pmc">PMC2885494</ArticleId><ArticleId IdType="pubmed">19423079</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., et al. (2020). Neurologic features in severe SARS-CoV-2 infection. N. Eng. J. Med. 382 2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbig B. E. (2016). Reaction time effects in lab- versus Web-based research: experimental evidence. Behav. Res. Methods 48 1718&#x2013;1724. 10.3758/s13428-015-0678-9</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13428-015-0678-9</ArticleId><ArticleId IdType="pubmed">26542972</ArticleId></ArticleIdList></Reference><Reference><Citation>Honjo K., van Reekum R., Verhoeff N. P. (2009). Alzheimer&#x2019;s disease and infection: do infectious agents contribute to progression of Alzheimer&#x2019;s disease? Alzheimer&#x2019;s Dement. 5 348&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">19560105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins R. O., Weaver L. K., Pope D., Orme J. F., Jr., Bigler E. D., Larson-Lohr V. (1999). Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 160 50&#x2013;56. 10.1164/ajrccm.160.1.9708059</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.160.1.9708059</ArticleId><ArticleId IdType="pubmed">10390379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J. A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., et al. (2021). Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144 1263&#x2013;1276. 10.1093/brain/awab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun J.-S., Luck S. J. (2007). Visual working memory as the substrate for mental rotation. Psychon. Bull. Rev. 14 154&#x2013;158. 10.3758/bf03194043</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/bf03194043</ArticleId><ArticleId IdType="pubmed">17546746</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna T. J., Ely E. W., Smith D. M., Langa K. M. (2010). Long-term cognitive impairment and functional disability among survivors of severe sepsis. Jama 304 1787&#x2013;1794. 10.1001/jama.2010.1553</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1553</ArticleId><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson J. C., Hart R. P., Gordon S. M., Shintani A., Truman B., May L., et al. (2003). Six-month neuropsychological outcome of medical intensive care unit patients. Critic. Care Med. 31 1226&#x2013;1234. 10.1097/01.CCM.0000059996.30263.94</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000059996.30263.94</ArticleId><ArticleId IdType="pubmed">12682497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli S. G., Dogan L., Sarikaya Z. T., Kara S., Akinci C., Kaya D., et al. (2020). Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 297 E232&#x2013;E235. 10.1148/radiol.2020201697</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201697</ArticleId><ArticleId IdType="pmc">PMC7507997</ArticleId><ArticleId IdType="pubmed">32384020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaser M., Foley &#xc9;M., Khandaker G. M. (2021). Neurocognitive performance in depressed patients with low-grade inflammation and somatic symptoms. Brain Behav. Immunity-Health 19:100409. 10.1016/j.bbih.2021.100409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100409</ArticleId><ArticleId IdType="pmc">PMC8749189</ArticleId><ArticleId IdType="pubmed">35036964</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F., Kruip M., Van der Meer N., Arbous M., Gommers D., Kant K., et al. (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombo. Res. 191 145&#x2013;147. 10.1016/j.thromres.2020.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraynak T. E., Marsland A. L., Wager T. D., Gianaros P. J. (2018). Functional neuroanatomy of peripheral inflammatory physiology: a meta-analysis of human neuroimaging studies. Neurosci. Biobehav. Rev. 94 76&#x2013;92. 10.1016/j.neubiorev.2018.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2018.07.013</ArticleId><ArticleId IdType="pmc">PMC6363360</ArticleId><ArticleId IdType="pubmed">30067939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M., Hohberger B., Hoffmanns J., F&#xfc;rst J., Herrmann M. (2021). Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 120 2838&#x2013;2847. 10.1016/j.bpj.2021.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guennec L., Devianne J., Jalin L., Cao A., Galanaud D., Navarro V., et al. (2020). Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia 61 e90&#x2013;e94. 10.1111/epi.16612</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16612</ArticleId><ArticleId IdType="pmc">PMC7361605</ArticleId><ArticleId IdType="pubmed">32589794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J. R., Chiesa-Estomba C. M., De Siati D. R., Horoi M., Le Bon S. D., Rodriguez A., et al. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Euro. Arch. Oto-Rhino-Laryngol. 277 2251&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li M., Wang M., Zhou Y., Chang J., Xian Y., et al. (2020). Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vascular Neurol. 5 279&#x2013;284. 10.1136/svn-2020-000431</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China. JAMA Neurol. 77 683&#x2013;690. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsland A. L., Gianaros P. J., Abramowitch S. M., Manuck S. B., Hariri A. R. (2008). Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatr. 64 484&#x2013;490. 10.1016/j.biopsych.2008.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.04.016</ArticleId><ArticleId IdType="pmc">PMC2562462</ArticleId><ArticleId IdType="pubmed">18514163</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J. P., Schr&#xf6;der A. S., Edler C., et al. (2020). Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19 919&#x2013;929. 10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer E. G., McGeer P. L. (2010). Neuroinflammation in Alzheimer&#x2019;s disease and mild cognitive impairment: a field in its infancy. J. Alzheimer&#x2019;s Dis. 19 355&#x2013;361. 10.3233/JAD-2010-1219</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1219</ArticleId><ArticleId IdType="pubmed">20061650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijajlovi&#x107; M. D., Pavlovi&#x107; A., Brainin M., Heiss W.-D., Quinn T. J., Ihle-Hansen H. B., et al. (2017). Post-stroke dementia&#x2013;a comprehensive review. BMC Med. 15:11. 10.1186/s12916-017-0779-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-017-0779-7</ArticleId><ArticleId IdType="pmc">PMC5241961</ArticleId><ArticleId IdType="pubmed">28095900</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A. H., Haroon E., Raison C. L., Felger J. C. (2013). Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anx. 30 297&#x2013;306. 10.1002/da.22084</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22084</ArticleId><ArticleId IdType="pmc">PMC4141874</ArticleId><ArticleId IdType="pubmed">23468190</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M. L., Toda H., Palmer T. D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 1760&#x2013;1765. 10.1126/science.1088417</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1088417</ArticleId><ArticleId IdType="pubmed">14615545</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., et al. (2020). A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 94 55&#x2013;58. 10.1016/j.ijid.2020.03.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (2020). COVID-19 Rapid Guideline: Managing The Long-Term Effects of COVID-19. Available online at https://www.nice.org.uk/guidance/ng1889. (accessed on Nov 11, 2021)</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Aebischer Perone S., Courvoisier D., Chappuis F., et al. (2021). COVID-19 symptoms: Longitudinal evolution and persistence in outpatient settings. Ann. Internal Med. 174 723&#x2013;725. 10.7326/M20-5926</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (2021). Prevalence of Ongoing Symptoms following Coronavirus (COVID-19) Infection in the UK: 1 April 2021. Available online at https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronavirusCOVID19infectionintheuk/1april2021
(accessed on Apr 1, 2021)</Citation></Reference><Reference><Citation>Oxley T. J., Mocco J., Majidi S., Kellner C. P., Shoirah H., Singh I. P., et al. (2020). Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 382:e60. 10.1056/NEJMc2009787</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P. P., Girard T. D., Jackson J. C., Morandi A., Thompson J. L., Pun B. T., et al. (2013). Long-term cognitive impairment after critical illness. N. Engl. J. Med. 369 1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce L., Davidson S. M., Yellon D. M. (2020). The cytokine storm of COVID-19: a spotlight on prevention and protection. Exp. Opin. Ther. Targets 24 723&#x2013;730. 10.1080/14728222.2020.1783243</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2020.1783243</ArticleId><ArticleId IdType="pubmed">32594778</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi L. S., Salsano E., Grimaldi M. (2020). Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 77 1028&#x2013;1029. 10.1001/jamaneurol.2020.2125</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2125</ArticleId><ArticleId IdType="pubmed">32469400</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. (2020). COVID-19&#x2013;associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 296 E119&#x2013;E120. 10.1148/radiol.2020201187</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C. M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A., Garc&#xed;a-Garc&#xed;a J. (2020). Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95 e1060&#x2013;e1070. 10.1212/WNL.0000000000009937</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Royet J. P., Plailly J. (2004). Lateralization of olfactory processes. Chem. Senses 29 731&#x2013;745. 10.1093/chemse/bjh067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjh067</ArticleId><ArticleId IdType="pubmed">15466819</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri S., Wolf P. A. (2007). Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 6 1106&#x2013;1114. 10.1016/S1474-4422(07)70291-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70291-0</ArticleId><ArticleId IdType="pubmed">18031707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims J. T., Krishnan V., Chang C.-Y., Engle S. M., Casalini G., Rodgers G. H., et al. (2021). Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J. Aller. Clin. Immunol. 147 107&#x2013;111. 10.1016/j.jaci.2020.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.031</ArticleId><ArticleId IdType="pmc">PMC7488591</ArticleId><ArticleId IdType="pubmed">32920092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C. E., et al. (2020). Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. Medrxiv 27 626&#x2013;631.</Citation></Reference><Reference><Citation>Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thrombo. Haemosta. 18 1094&#x2013;1099. 10.1111/jth.14817</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M. W., Kim S. S., Lindsell C. J., Billig Rose E., Shapiro N. I., Files D. C., et al. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States. March&#x2013;June 2020. Morb. Mortal. Weekly Rep. 69 993&#x2013;998. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Yang Y., Liang X., Gao B., Liu M., Li W., et al. (2020). COVID-19 associated ischemic stroke and hemorrhagic stroke: incidence, potential pathological mechanism, and management. Front. Neurol. 11:1152. 10.3389/fneur.2020.571996</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.571996</ArticleId><ArticleId IdType="pmc">PMC7652923</ArticleId><ArticleId IdType="pubmed">33193019</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker A., Anson M., Harky A. (2020). Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol. Scandin. 142 14&#x2013;22. 10.1111/ane.13266</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13266</ArticleId><ArticleId IdType="pmc">PMC7273036</ArticleId><ArticleId IdType="pubmed">32412088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.-P., L&#xfc;tgehetmann M., Steurer S., Edler C., Heinemann A., et al. (2020). Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Annal. Internal Med. 173 268&#x2013;277. 10.7326/M20-2003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang-Hua Y., Le-Min W., Ai-Bin L., Zhu G., Riquan L., Xu-You Z., et al. (2010). Severe acute respiratory syndrome and venous thromboembolism in multiple organs. Am. J. Respir. Critic. Care Med. 182 436&#x2013;437. 10.1164/ajrccm.182.3.436</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.182.3.436</ArticleId><ArticleId IdType="pubmed">20675682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Tecson K. M., McCullough P. A. (2020). Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev. Cardiovasc. Med. 21 315&#x2013;319. 10.31083/j.rcm.2020.03.126</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2020.03.126</ArticleId><ArticleId IdType="pubmed">33070537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Shen D., Zhou H., Liu J., Chen S. (2020). Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 19 383&#x2013;384. 10.1016/s1474-4422(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M. E., Hastie C., Roderick P., Yao G., et al. (2021). Characteristics of Long Covid: findings from a social media survey. medRxiv [preprint]. 10.1101/2021.03.21.21253968</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.21.21253968</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotova E., Nicoll J. A., Kalaria R., Holmes C., Boche D. (2010). Inflammation in Alzheimer&#x2019;s disease: relevance to pathogenesis and therapy. AlzheimersAlzheimers Res. Ther. 2 1&#x2013;9. 10.1186/alzrt24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt24</ArticleId><ArticleId IdType="pmc">PMC2874260</ArticleId><ArticleId IdType="pubmed">20122289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>